# A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

> **NCT05852028** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Lymphoma
- DLBCL
- T Cell Lymphoma

## Interventions

- **DRUG:** Selinexor

## Key facts

- **NCT ID:** NCT05852028
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-15
- **Primary completion:** 2024-10-10
- **Final completion:** 2025-10-18
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05852028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05852028, "A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05852028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*